Tapewire

OTC · USD

ZOMDF

Zomedica Corp.

Export transactions ↓
Tapewire entity
6884
SEC CIK
0001684144
Parsed reports
182

Last 12 months

Inside the activity.

16 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 2026120
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 17, 2025 Filed Mar 18, 2025 20:52 UTC PurchaseCommon Stock, without par value 100,647 $0.07 $7,045.29
Disclosure

SEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 2

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 875,647

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:52 UTC PurchaseCommon Stock, without par value 500,000 $0.06 $32,000.00
Disclosure

SEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 1

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 775,000

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:48 UTC PurchaseCommon Stock, without par value 143,000 $0.06 $8,437.00
Disclosure

SEC source: 0001654954-25-002966 · section16.xml · nonDerivative · entry 1

MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,000

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:40 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 179,328 $0.06 $10,759.68
Disclosure

SEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 4

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:40 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 191,817 $0.06 $11,509.02
Disclosure

SEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 3

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 820,672

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:40 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 118,855 $0.06 $6,893.59
Disclosure

SEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 2

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 628,855

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:40 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 10,000 $0.05 $540.00
Disclosure

SEC source: 0001654954-25-002960 · section16.xml · nonDerivative · entry 1

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 510,000

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:36 UTC
Klass Russell KevinSr Vice President of Sales
PurchaseCommon Stock, without $0.070 par value 699,980 $0.07 $48,998.60
Disclosure

SEC source: 0001654954-25-002954 · section16.xml · nonDerivative · entry 1

Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200,030

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:38 UTC PurchaseCommon Stock, without par value 500,000 $0.06 $30,000.00
Disclosure

SEC source: 0001654954-25-002956 · section16.xml · nonDerivative · entry 1

Blair Anthony K · CIK 0001297970 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Read SEC document
March 17, 2025 Filed Mar 18, 2025 20:24 UTC PurchaseCommon Stock, without par value 100,000 $0.07 $6,900.00
Disclosure

SEC source: 0001654954-25-002951 · section16.xml · nonDerivative · entry 1

Williams Rodney James · CIK 0001722780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document
March 17, 2025 Filed Mar 19, 2025 15:47 UTC
Jordan ScottChief Financial Officer
PurchaseCommon Stock, without par value 300,000 $0.06 $18,600.00
Disclosure

SEC source: 0001654954-25-003016 · section16.xml · nonDerivative · entry 1

Jordan Scott · CIK 0001769747 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Read SEC document
March 17, 2025 Filed Mar 20, 2025 13:52 UTC PurchaseCommon Stock, without par value 100,000 $0.07 $6,900.00
Disclosure

SEC source: 0001654954-25-003059 · section16.xml · nonDerivative · entry 1

Williams Rodney James · CIK 0001722780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,900

F1 · balance_after: A correction is being made to the Form K filed on 3/18/2025 to add shares previously held by Mr. Williams and correct total securities beneficially owned following the transaction

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 34,725 $0.07 $2,465.48
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 6

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 2,378,485

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 4,265 $0.07 $298.55
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 5

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 2,343,760

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 731,368 $0.07 $49,733.02
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 4

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 2,399,495

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 68,000 $0.07 $4,556.00
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 3

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 1,608,127

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 100,647 $0.07 $7,045.29
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 2

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 1,540,127

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment PurchaseCommon Stock, without par value 500,000 $0.06 $32,000.00
Disclosure

SEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 1

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey M. Rowe Living Trust

Disclosed balance after: 1,439,480

F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.

Read SEC document
February 21, 2025 Filed Feb 24, 2025 21:30 UTC
Klass Russell KevinSr Vice President of Sales
GrantOption to buy common stock · Derivative 200,000 $0.00 Strike: $0.12 $0.00
Disclosure

SEC source: 0001654954-25-001855 · section16.xml · derivative · entry 1

Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2030-02-20

F1 · derivative.exercise_date: one fourth of the options vest on the first anniversary of the grant date and 1/48 vest each month thereafter until fully vested on 2/20/2029

Read SEC document
January 01, 2025 Filed Jan 3, 2025 19:16 UTC
Jordan ScottChief Financial Officer
GrantOptions to buy common stock · Derivative 5,000,000 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001654954-25-000095 · section16.xml · derivative · entry 1

Jordan Scott · CIK 0001769747 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 5,000,000 shares

Expires 2034-12-31

F1 · derivative.exercise_date: The options shall vest over a period of four years; 25% shall vest on the first anniversary of the date of issuance and 1/48th shall vest each month thereafter

Read SEC document
November 11, 2024 Filed Nov 12, 2024 14:00 UTC PurchaseCommon Stock, without par value 100,000 $0.12 $12,100.00
Disclosure

SEC source: 0001654954-24-014107 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,425,000

Read SEC document
November 11, 2024 Filed Nov 12, 2024 11:11 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 100,000 $0.12 $12,200.00
Disclosure

SEC source: 0001654954-24-014059 · section16.xml · nonDerivative · entry 1

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Read SEC document
November 11, 2024 Filed Nov 12, 2024 11:11 UTC
Klass Russell KevinVice President of Sales
PurchaseCommon Stock, without par value 289,800 $0.12 $35,065.80
Disclosure

SEC source: 0001654954-24-014057 · section16.xml · nonDerivative · entry 2

Klass Russell Kevin · CIK 0001999774 · Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500,050

Read SEC document
November 11, 2024 Filed Nov 12, 2024 11:11 UTC
Klass Russell KevinVice President of Sales
PurchaseCommon Stock, without par value 210,200 $0.12 $25,224.00
Disclosure

SEC source: 0001654954-24-014057 · section16.xml · nonDerivative · entry 1

Klass Russell Kevin · CIK 0001999774 · Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,210,250

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:15 UTC GrantStock Appreciation Rights · Derivative 1,975,033 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014273 · section16.xml · derivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,975,033

Underlying: Common · 1,975,033 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:13 UTC GrantStock Appreciation Rights · Derivative 1,823,107 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014270 · section16.xml · derivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,823,107

Underlying: Common · 1,823,107 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:08 UTC
DeHaan-Fullerton KarenGeneral Counsel/Corporate Secy
GrantOptions to Buy Common Stock · Derivative 500,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014266 · section16.xml · derivative · entry 1

DeHaan-Fullerton Karen · CIK 0001934689 · General Counsel/Corporate Secy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common · 500,000 shares

Expires 2034-11-10

F1 · derivative.exercise_date: one fourth of the options vest on the first anniversary of the grant date and 1/48 vest each month thereafter until fully vested on 11/10/2028

Read SEC document
November 11, 2024 Filed Nov 13, 2024 16:09 UTC
Cohen RobertDirector
GrantStock Appreciation Rights · Derivative 1,823,107 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014267 · section16.xml · derivative · entry 1

Cohen Robert · CIK 0001815574 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,823,107

Underlying: Common · 1,823,107 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:14 UTC
Whelan SeanDirector
GrantStoock Appreciation Rights · Derivative 1,975,033 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014272 · section16.xml · derivative · entry 1

Whelan Sean · CIK 0001418307 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,975,033

Underlying: Common · 1,975,033 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:13 UTC GrantStock Appreciation Rights · Derivative 2,126,959 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014271 · section16.xml · derivative · entry 1

Rowe Jeffrey M · CIK 0001619009 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,126,959

Underlying: Common · 2,126,959 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:12 UTC GrantStock Appreciation Rights · Derivative 1,975,033 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014269 · section16.xml · derivative · entry 1

Nichols Pamela · CIK 0001944747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,975,033

Underlying: Common · 1,975,033 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:11 UTC GrantStock Appreciation Rights · Derivative 1,823,107 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014268 · section16.xml · derivative · entry 1

MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,823,107

Underlying: Common · 1,823,107 shares

Expires 2034-11-10

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:07 UTC GrantOptions to Buy Common Stock · Derivative 400,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014265 · section16.xml · derivative · entry 1

Blair Anthony K · CIK 0001297970 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2034-11-10

F1 · derivative.exercise_date: one fourth of the options vest on the first anniversary of the grant date and 1/48 vest each month thereafter until fully vested on 11/10/2028

Read SEC document
November 10, 2024 Filed Nov 26, 2024 21:09 UTC Amendment GrantStock Appreciation Rights · Derivative 1,975,033 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001654954-24-014916 · section16.xml · derivative · entry 1

Williams Rodney James · CIK 0001722780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,975,033

Underlying: Common · 1,975,033 shares

Expires 2034-11-10

F1 · date: Amendment to correct name of recipient.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 21:07 UTC PurchaseCommon Stock, without par value 150,000 $0.12 $18,450.00
Disclosure

SEC source: 0001654954-24-014264 · section16.xml · nonDerivative · entry 1

Blair Anthony K · CIK 0001297970 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Read SEC document
September 05, 2024 Filed Sep 5, 2024 18:30 UTC
HEATON LARRY C IIDirector · CEO
PurchaseCommon Stock, without par value 100,000 $0.13 $12,500.00
Disclosure

SEC source: 0001654954-24-011544 · section16.xml · nonDerivative · entry 1

HEATON LARRY C II · CIK 0001213207 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 400,000

Read SEC document
August 28, 2024 Filed Aug 28, 2024 20:19 UTC PurchaseCommon Stock, without par value 100,000 $0.13 $12,900.00
Disclosure

SEC source: 0001654954-24-011206 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,325,000

Read SEC document
August 20, 2024 Filed Aug 20, 2024 19:55 UTC PurchaseCommon Stock, without par value 100,000 $0.14 $14,200.00
Disclosure

SEC source: 0001654954-24-010950 · section16.xml · nonDerivative · entry 1

Blair Anthony K · CIK 0001297970 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Read SEC document
June 12, 2024 Filed Jun 13, 2024 22:32 UTC
Klass Russell KevinVice President of Sales
PurchaseCommon Stock, without par value 299,993 $0.16 $46,528.91
Disclosure

SEC source: 0001654954-24-007748 · section16.xml · nonDerivative · entry 1

Klass Russell Kevin · CIK 0001999774 · Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,050

F1 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1520 to $0.1559, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
June 11, 2024 Filed Jun 12, 2024 20:15 UTC
Klass Russell KevinVice President of Sales
PurchaseCommon Stock, without par value 500,000 $0.15 $75,100.00
Disclosure

SEC source: 0001654954-24-007663 · section16.xml · nonDerivative · entry 2

Klass Russell Kevin · CIK 0001999774 · Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,700,057

F2 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
June 10, 2024 Filed Jun 11, 2024 20:15 UTC
Donato PeterChief Financial Officer
PurchaseCommon Stock, without par value 25,000 $0.15 $3,797.50
Disclosure

SEC source: 0001654954-24-007615 · section16.xml · nonDerivative · entry 1

Donato Peter · CIK 0001408320 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:15 UTC
Klass Russell KevinVice President of Sales
PurchaseCommon Stock, without par value 200,007 $0.15 $29,941.05
Disclosure

SEC source: 0001654954-24-007663 · section16.xml · nonDerivative · entry 1

Klass Russell Kevin · CIK 0001999774 · Vice President of Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200,057

F1 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
May 17, 2024 Filed May 17, 2024 19:08 UTC PurchaseCommon Stock, without par value 50,000 $0.17 $8,500.00
Disclosure

SEC source: 0001654954-24-006605 · section16.xml · nonDerivative · entry 2

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,225,000

Read SEC document
May 17, 2024 Filed May 17, 2024 19:08 UTC PurchaseCommon Stock, without par value 50,000 $0.18 $8,950.00
Disclosure

SEC source: 0001654954-24-006605 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,175,000

Read SEC document
May 16, 2024 Filed May 17, 2024 14:08 UTC PurchaseCommon Stock, without par value 25,000 $0.18 $4,600.00
Disclosure

SEC source: 0001654954-24-006580 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,125,000

Read SEC document
May 14, 2024 Filed May 15, 2024 20:30 UTC PurchaseCommon Stock, without par value 30,594 $0.14 $4,283.16
Disclosure

SEC source: 0001654954-24-006413 · section16.xml · nonDerivative · entry 2

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100,000

Read SEC document
May 14, 2024 Filed May 15, 2024 20:30 UTC PurchaseCommon Stock, without par value 19,406 $0.14 $2,697.43
Disclosure

SEC source: 0001654954-24-006413 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,069,406

Read SEC document
May 13, 2024 Filed May 13, 2024 21:07 UTC PurchaseCommon Stock, without par value 100,000 $0.14 $14,200.00
Disclosure

SEC source: 0001654954-24-006092 · section16.xml · nonDerivative · entry 1

HEATON LARRY C II · CIK 0001213207 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Read SEC document
May 13, 2024 Filed May 14, 2024 20:31 UTC PurchaseCommon Stock, without par value 100,000 $0.14 $14,000.00
Disclosure

SEC source: 0001654954-24-006245 · section16.xml · nonDerivative · entry 1

POWERS JOHNNY D · CIK 0001134545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,050,000

Read SEC document
May 13, 2024 Filed May 14, 2024 20:31 UTC PurchaseCommon Stock, without par value 150,000 $0.14 $21,000.00
Disclosure

SEC source: 0001654954-24-006244 · section16.xml · nonDerivative · entry 1

Blair Anthony K · CIK 0001297970 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.